ADC Therapeutics SA at its AGM held on June 10, 2021 approved the election of Viviane Monges to the board of directors. Ms. Monges has 30 years of executive-level financial leadership experience with global corporations, predominantly in the pharmaceutical industry. She is a veteran Chief Financial Officer who has worked cross-functionally at both large and small companies deploying innovative strategies and building out finance teams. Ms. Monges was CFO of the Business Excellence Division at Nestlé. Prior to that, she spent nearly two decades leading financial operations for divisions of three pharmaceutical companies. She served as Group CFO at Galderma S.A. Ms. Monges served at Novartis A/G as EMEA CFO and then as Global CFO of the OTC Division. At Wyeth Pharmaceuticals/Pfizer she served as CFO of the Europe Region unit and as CFO of the Global Pharma Business unit. Ms. Monges provides financial and leadership counsel to companies as a board member of several innovative healthcare corporations, including DBV Technologies and Voluntis in France, UCB in Belgium, and Novo Holdings A/S in Denmark. Until May 2021, Ms. Monges also served on the board of Idorsia Pharmaceuticals.